{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-058622","form_type":"8-K","ticker":"CARM","cik":"0001485003","company_name":"Carisma Therapeutics Inc.","filed_at":"2025-06-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.426140+00:00","generated_at":"2026-05-19T10:33:23.431480+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Carisma Therapeutics secures Nasdaq listing extension with transfer to Capital Market, strict conditions to Oct 7, 2025","bullets":["Nasdaq Panel granted exception; listing transferred to Nasdaq Capital Market effective June 12, 2025.","Must demonstrate closing bid price ≥$1.00 for 10 consecutive sessions by Oct 7, 2025.","Must complete a strategic transaction and meet all initial listing requirements for Capital Market by Oct 7.","Company had previously failed MVLS ($50M), MVPHS ($15M), and Bid Price ($1.00) rules.","Panel may reconsider if conditions not met; no assurance of compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-058622","json":"https://secwatch.observer/filing/0001104659-25-058622.json","markdown":"https://secwatch.observer/filing/0001104659-25-058622.md","text":"https://secwatch.observer/filing/0001104659-25-058622.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1485003/000110465925058622/0001104659-25-058622-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1485003/000110465925058622/tm2517769d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T10:33:23.431480+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}